Dr. Garry Honey

 

University of Cambridge

Department of Psychiatry

Brain Mapping Unit 

 

Tel. +44 (0)1223 764678 

email: gh242-AT-cam.ac.uk dr. gary honey


I am a cognitive neuroscientist sponsored by the UK Medical Research Council (MRC) to undertake a research programme investigating the neurobiological basis of psychosis. My primary research tools involve the combined application of functional magnetic resonance imaging (fMRI) and neuropharmacological challenges, using psychotogenic drugs such as ketamine and THC (psychoactive component of cannabis) as a means to reproduce in healthy volunteers the symptoms observed in patients with schizophrenia and other mental illnesses. I aim to explore the relationship between clinical symptoms in psychiatry and the breakdown of related fundamental cognitive processes, and the patterns of brain function which underpin them. I am interested in the neurophysiological, psychological, social, and genetic factors which may predispose individuals to specific forms of psychosis. Other investigative procedures involve the use Transcranial Magnetic Stimulation (TMS) and psychophysiological measurements, such as prepulse inhibition (PPI). Ultimately, I hope that these techniques may improve understanding of the pathophysiology of schizophrenia, and directly inform the process of anti-psychotic drug discovery.

 

For further information, please follow the links below:

 Local Links:

University of Cambridge

Cambridge Neuroscience

          Department of Psychiatry

          Brain Mapping Unit 

          Behavioural and Clinical Neurosciences Institute

          Department of Experimental Psychology


          MRC Cognition & Brain Sciences Unit, Cambridge

          Wolfson Brain Imaging Centre